MedTrace Logo

Impact of Radiation Therapy on Breast Conservation in DCIS

NCT02248662 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3436

Last updated 2019-09-06

Study results available
· View outcomes & findings →

Summary

Large regional variation exists in the use of radiotherapy after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS). Although patients who do not receive initial radiotherapy for DCIS are candidates for subsequent BCS if they experience a second breast event, many undergo mastectomy instead.

Conditions

  • DCIS

Sponsors & Collaborators

Principal Investigators

  • Rinaa S. Punglia, MD, MPH · Dana-Farber Cancer Institute

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02248662 on ClinicalTrials.gov